Iovance Biotherapeutics, Inc.

IOVA·NasdaqGM·Healthcare
Compare
8.70−0.13 (−1.47%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
Pre-market8.90+0.20 (+2.30%)

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close8.83
Open8.87
Day range8.479.09
52-week range1.7615.37
Off day high−4.29%
Off 52-week high−43.40%
Volume17.29M
Avg. volume (3M)17.42M
Market cap3.94B
EPS (TTM)-0.6900
Forward P/E-44.44
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.76
Shares outstanding452.97M
Short interest13.91% of float
Earnings dateNov 5, 2026
Analyst target14.20
Profit margin−89.09%

Against its peers

Compare in full ›
IOVA 0A3M.IL IMCR IDYA INCY 688382.SS
Market cap 3.94B 25.17B 1.51B 3.12B 25.04B 8.38B
P/E (TTM) — 5.1 — — 62.7 —
Forward P/E -44.4 5.1 -37.7 -7.9 14.2 -43.8
Price/book 5.4 1.1 3.6 2.9 4.4 6.6
Dividend yield — — — — — —
1-year change +387.85% −16.75% −2.50% +5.63% +11.25% −48.70%
Today −1.47% +2.81% −2.66% +3.29% +4.47% +4.33%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All IOVA news ›
Trefis·Negative

Is 50% Crash Risk For Iovance Stock Real?

Shares of Iovance Biotherapeutics (IOVA) fell 35.4% on October 29, 2026, though the stock remains up 336.5% over the past year. Losing half its value is familiar territory for this stock. Across 5 of the 12 market shocks it has traded…

Seeking Alpha··2 outletsPositive

Iovance Biotherapeutics, Inc. (IOVA) Discusses Positive Lifileucel Data and Precision TIL Strategy in Non-small Cell Lung Cancer Transcript

Iovance Biotherapeutics, Inc. (IOVA) Discusses Positive Lifileucel Data and Precision TIL Strategy in Non-small Cell Lung Cancer October 29, 2026 8:30 AM EDT Sara Pellegrino - Senior Vice President of Investor Relations & Corporate…

More from 1 other outlet

From the 4Search news index, newest first.

In the news

33mentions in 30 days
19with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 33 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance